全球血液黏度計市場

到 2030 年，全球血液黏度計市場規模將達到 46 億美元

全球血液黏度計市場規模預計在2024年為34億美元，預計到2030年將達到46億美元，2024年至2030年的複合年成長率為4.9%。旋轉黏度計產品是本報告分析的細分市場之一，預計其複合年成長率為4.0%，到分析期結束時將達到30億美元。毛細管黏度計產品細分市場在分析期間的複合年成長率預計為6.8%。

美國市場規模將達 9.386 億美元；中國市場預期複合年成長率為 7.7%

美國血液黏度計市場規模預計在2024年達到9.386億美元。預計到2030年，作為世界第二大經濟體的中國市場規模將達到9.011億美元，在2024-2030年的分析期內，複合年成長率為7.7%。其他值得關注的區域市場包括日本和加拿大，預計在分析期間內，這兩個市場的複合年成長率分別為2.4%和4.9%。在歐洲，預計德國市場的複合年成長率為3.1%。

全球血液黏度計市場-主要趨勢與促進因素摘要

為什麼血液黏度測量在心血管和血液學評估中具有越來越重要的臨床意義？

隨著越來越多的醫療相關人員認知到血液黏度作為心血管、代謝和血液系統疾病診斷和管理中關鍵生物標記的重要性，血液黏度計的臨床應用也越來越廣泛。血液黏度，即血液的稠度和黏稠度，在決定血管阻力和總循環效率方面起著關鍵作用。血液黏度升高與多種疾病有關，包括高血壓、動脈粥狀硬化、糖尿病、中風和周邊動脈疾病。因此，臨床醫生將黏度測量納入其常規診斷和風險分層方案中，尤其是針對老年人、糖尿病患者和慢性發炎性疾病患者等高風險族群。與僅關注膽固醇、血壓和血糖水平的傳統診斷方法不同，黏度計可以捕捉血液在不同剪切速率下的動態行為，從而提供更全面的血管健康狀況圖。這些測量對於了解可能先於重大心血管事件發生的微循環功能障礙和內皮壓力尤其有價值。隨著個人化醫療和預防醫學的蓬勃發展，對血液黏度計等精準的即時診斷工具的需求日益成長。醫院、研究機構和專科診所擴大採用此類設備來改善診斷模型並最佳化治療方案。在這個不斷發展的醫療領域，血液黏度計已不再只是測試儀器，而逐漸成為實現精準心血管護理的重要工具。

技術創新如何提高血液黏度計的準確性和可及性？

黏度計技術的進步已將這些儀器轉變為高度精密、易於使用的診斷工具，使其更易於應用於臨床和研究。傳統的黏度計需要大量的血液，並且涉及複雜的校準和手動操作，限制了其在專業實驗室以外的應用。如今的血液黏度計整合了微流體系統、數位感測器和自動化分析軟體，大大提高了易用性、速度和準確性。許多最新型號可以對一滴血液進行多次剪切速率測量，即時提供詳細的流變曲線。熱穩定性和機械穩定性的創新提高了測量的可重複性，而觸控螢幕介面和無線連接則提高了易用性和數據完整性。這些技術改進實現了與電子健康記錄(EMR) 的無縫連接，使臨床醫生能夠將血液黏度作為慢性疾病管理的一部分進行長期監測。此外，微型可攜式黏度計已被開發用於床邊診斷、急救和行動醫療單元，擴大了其在分散式環境中的應用範圍。人工智慧和機器學習也開始發揮作用，其演算法能夠解讀複雜的黏度模式，支援早期診斷和預測分析。隨著經濟高效、擴充性的解決方案越來越多，技術創新正在推動血液黏度計從診斷測試的邊緣應用邁向主流臨床工作流程，從而擴大其在更廣泛的醫療保健環境中的效用。

多樣化的臨床應用如何擴大血液黏度計的市場機會？

血液黏度計在眾多醫學學科中的多功能性開啟了巨大的市場潛力。在心臟病學中，它們用於評估血流動力學壓力和血栓形成風險，為抗凝血劑和他汀類藥物的使用提供重要數據。在內分泌學中，血液黏度測量有助於評估糖尿病和METABOLIC INC.症候群患者的微血管併發症。腫瘤學家使用黏度測定數據來監測某些骨髓惡性腫瘤（例如多發性骨髓瘤）患者的高黏度症候群。在神經病學中，血液黏度顯示出評估中風風險和認知能力下降的潛力，尤其是在老年人群中。血液學家利用這些設備來診斷和監測紅血球增多症、貧血和凝血障礙。此外，研究人員正在研究血液黏度在發炎和自體免疫疾病以及像 COVID-19 這樣的感染疾病中的作用，高凝血狀態已成為這些疾病的嚴重併發症。製藥公司也在臨床試驗中使用血液黏度計來評估臨床實驗藥物（尤其是針對血管系統的藥物）的流變效應。這種廣泛的應用正在推動醫院、診斷實驗室、學術機構和生技公司的需求。此外，運動醫學和健康中心也開始採用黏度計來監測精英運動員的運動表現和心血管篩檢。隨著血液黏度作為關鍵健康指標的認可度不斷提高，其在多學科護理模式中的應用正在迅速擴展，為製造商和醫療保健提供者開闢了新的成長途徑。

哪些因素推動了血液黏度計市場的成長？

血液黏度計市場的成長受到醫療、技術、經濟和人口等多種因素的共同驅動，這些因素反映了現代醫療保健重點的轉變。其中一個主要促進因素是全球心血管和代謝疾病負擔的不斷加重，這促使臨床醫生尋求更精準的診斷工具，而不僅僅是標準指標。隨著文明病在已開發經濟體和新興經濟體中日益普遍，對能夠預測血管健康狀況的早期檢測工具的需求也日益成長。技術創新使這些設備變得更小、更實惠、更易於使用，從而促進了它們在小型診所和分散式醫療機構中的部署。醫療保健系統越來越重視預防保健和基於價值的治療結果，這與血液黏度計的早期診斷能力一致。強調全面心血管風險評估的監管支持和更新的臨床指南進一步證明了血液黏度計在臨床實踐中的作用。同時，對醫學研究和診斷基礎設施的投資不斷增加，尤其是在亞太地區和拉丁美洲，正在開拓新的市場並擴大其全球影響力。教育舉措和繼續醫學教育 (CME) 計畫正在幫助臨床醫生了解血液黏度的重要性以及如何解讀黏度數據，從而提高其使用率和可靠性。最後，黏度計與數位健康平台和數據分析工具的整合，正在提升效用。這些共同的促進因素為血液黏度計市場在臨床和商業領域的持續擴張奠定了堅實的基礎。

部分

產品（旋轉黏度計、毛細管黏度計）；最終用途（醫院最終用途、診斷最終用途、其他最終用途）

受訪公司範例（41家值得關注的公司）

• A&D HOLON Holdings Co., Ltd.
• AMETEK Inc.（Brookfield Engineering）
• Anton Paar GmbH
• ATAGO Co., Ltd.
• Benson Viscometers Ltd.
• BioFluid Technology Inc.
• Cambridge Viscosity Inc.
• Cannon Instrument Company
• Fann Instrument Company
• Grifols, SA
• Haemonetics Corporation
• Health Onvector
• KYOTO ELECTRONICS MANUFACTURING CO., LTD.
• LAUDA Scientific GmbH
• Lamy Rheology
• Microvisk Ltd.
• PCE Instruments
• Radiometer Medical ApS
• RheoSense Inc.
• Thermo Fisher Scientific Inc.

人工智慧整合

我們正在利用可操作的專家內容和人工智慧工具來改變市場和競爭情報。

Global 特定產業SLM 的典型規範，而是建立了一個從全球專家收集的內容庫，其中包括視訊錄影、部落格、搜尋引擎研究以及大量的公司、產品/服務和市場數據。

關稅影響係數

全球產業分析師根據公司總部所在國家、製造地、進出口狀況（成品和原始OEM）預測其競爭態勢的變化。這種複雜且多面向的市場動態預計將以多種方式影響競爭對手，包括銷貨成本成本 (COGS) 上升、盈利下降、供應鏈重組以及其他微觀和宏觀市場動態。

目錄

第1章調查方法

第2章執行摘要

• 市場概覽
• 主要企業
• 市場趨勢和促進因素
• 全球市場展望

第3章市場分析

• 美國
• 加拿大
• 日本
• 中國
• 歐洲
• 法國
• 德國
• 義大利
• 英國
• 西班牙
• 俄羅斯
• 其他歐洲國家
• 亞太地區
• 澳洲
• 印度
• 韓國
• 其他亞太地區
• 拉丁美洲
• 阿根廷
• 巴西
• 墨西哥
• 其他拉丁美洲
• 中東
• 伊朗
• 以色列
• 沙烏地阿拉伯
• 阿拉伯聯合大公國
• 其他中東地區
• 非洲

第4章 競賽

Global Blood Viscometers Market to Reach US$4.6 Billion by 2030

The global market for Blood Viscometers estimated at US$3.4 Billion in the year 2024, is expected to reach US$4.6 Billion by 2030, growing at a CAGR of 4.9% over the analysis period 2024-2030. Rotational Viscometers Product, one of the segments analyzed in the report, is expected to record a 4.0% CAGR and reach US$3.0 Billion by the end of the analysis period. Growth in the Capillary Viscometers Product segment is estimated at 6.8% CAGR over the analysis period.

The U.S. Market is Estimated at US$938.6 Million While China is Forecast to Grow at 7.7% CAGR

The Blood Viscometers market in the U.S. is estimated at US$938.6 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$901.1 Million by the year 2030 trailing a CAGR of 7.7% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 2.4% and 4.9% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 3.1% CAGR.

Global Blood Viscometers Market - Key Trends & Drivers Summarized

Why Are Blood Viscometers Gaining Clinical Importance in Cardiovascular and Hemorheological Assessments?

Blood viscometers are gaining heightened clinical relevance as the healthcare community increasingly recognizes the importance of blood viscosity as a key biomarker in diagnosing and managing cardiovascular, metabolic, and hematologic conditions. Blood viscosity, or the thickness and stickiness of blood, plays a critical role in determining vascular resistance and overall circulatory efficiency. Elevated blood viscosity is linked to a range of disorders, including hypertension, atherosclerosis, diabetes, stroke, and peripheral artery disease. Consequently, clinicians are integrating viscometric assessments into routine diagnostics and risk stratification protocols, particularly for high-risk populations such as the elderly, diabetics, and patients with chronic inflammatory conditions. Unlike conventional diagnostics that often focus on cholesterol, blood pressure, or glucose levels alone, viscometers provide insight into the mechanical behavior of blood under various shear rates-offering a more holistic view of vascular health. These measurements are particularly valuable in understanding microcirculatory dysfunction and endothelial stress, which can precede major cardiovascular events. As personalized and preventive medicine gains momentum, the need for accurate, point-of-care tools like blood viscometers is intensifying. Hospitals, research institutions, and specialty clinics are increasingly adopting these devices to refine their diagnostic models and optimize treatment plans. In this evolving medical landscape, blood viscometers are emerging not just as laboratory tools but as critical enablers of precision cardiovascular care.

How Are Technological Innovations Enhancing the Accuracy and Accessibility of Blood Viscometers?

Advancements in viscometer technology are transforming these instruments into highly sophisticated and user-friendly diagnostic tools, making them more accessible for both clinical and research applications. Traditional viscometers required larger blood volumes, complex calibration, and manual operation, limiting their widespread use outside of specialized labs. Today’s blood viscometers incorporate microfluidic systems, digital sensors, and automated analysis software that significantly improve ease of use, speed, and precision. Many newer models can perform multiple shear rate measurements with a single drop of blood, offering detailed rheological profiles in real time. Innovations in thermal and mechanical stabilization have improved the reproducibility of results, while touchscreen interfaces and wireless connectivity enhance usability and data integration. These technological upgrades allow for seamless connection with electronic medical records (EMRs), enabling clinicians to monitor changes in blood viscosity over time as part of chronic disease management. Additionally, miniaturized and portable viscometers are being developed for bedside diagnostics, emergency care, and mobile health units, increasing their application scope in decentralized settings. Artificial intelligence and machine learning are also beginning to play a role, with algorithms capable of interpreting complex viscosity patterns to support early diagnosis and predictive analytics. As cost-effective and scalable solutions continue to emerge, technological innovation is pushing blood viscometers from the periphery of diagnostic testing into mainstream clinical workflows, expanding their utility across a growing range of healthcare environments.

How Are Diverse Clinical Applications Expanding Market Opportunities for Blood Viscometers?

The versatility of blood viscometers across a wide array of medical disciplines is significantly broadening their market potential. In cardiology, they are used to assess hemodynamic stress and thrombotic risk, providing vital data that can inform the use of anticoagulants and statins. In endocrinology, blood viscosity measurements help evaluate microvascular complications in patients with diabetes and metabolic syndrome. Oncologists use viscometric data to monitor hyperviscosity syndrome, which can occur in patients with certain hematologic malignancies such as multiple myeloma. In neurology, blood viscosity has shown potential in assessing stroke risk and cognitive decline, particularly among aging populations. Hematologists rely on these devices to diagnose and monitor polycythemia, anemia, and blood clotting disorders. Additionally, researchers are investigating the role of blood viscosity in inflammatory diseases, autoimmune conditions, and even infectious diseases like COVID-19, where hypercoagulability has emerged as a serious complication. Pharmaceutical companies are also using blood viscometers in clinical trials to evaluate the rheological effects of investigational drugs, particularly those targeting the vascular system. This wide range of applications is fueling demand in hospitals, diagnostic labs, academic institutions, and biotech firms. Moreover, sports medicine and wellness centers are beginning to adopt viscometers for performance monitoring and cardiovascular screening in elite athletes. As awareness of blood viscosity as a critical health metric grows, its integration into multidisciplinary care models is rapidly expanding, presenting new growth avenues for manufacturers and healthcare providers alike.

What Are the Key Drivers Behind the Growth of the Blood Viscometers Market?

The growth in the blood viscometers market is driven by a confluence of medical, technological, economic, and demographic factors that reflect the shifting priorities of modern healthcare. One of the primary drivers is the rising global burden of cardiovascular and metabolic diseases, which are prompting clinicians to seek more nuanced diagnostic tools beyond standard markers. As lifestyle diseases become more prevalent in both developed and emerging economies, there is a growing demand for early detection tools that can offer predictive insights into vascular health-something blood viscometers are uniquely positioned to deliver. Technological innovation has also made these devices more compact, affordable, and user-friendly, facilitating adoption in smaller clinics and decentralized care settings. Healthcare systems are increasingly prioritizing preventive care and value-based outcomes, both of which align with the early diagnostic capabilities of blood viscometers. Regulatory support and clinical guideline updates that emphasize comprehensive cardiovascular risk assessment are further legitimizing their role in practice. In parallel, increased investment in medical research and diagnostic infrastructure-particularly in Asia-Pacific and Latin America-is opening new markets and expanding global reach. Educational initiatives and continuing medical education (CME) programs are helping clinicians understand the significance of blood viscosity and how to interpret viscometric data, enhancing usage and trust. Lastly, the integration of viscometers with digital health platforms and data analytics tools is increasing their utility in longitudinal patient monitoring and chronic disease management. Together, these drivers are laying a strong foundation for the sustained expansion of the blood viscometers market in both clinical and commercial domains.

SCOPE OF STUDY:

The report analyzes the Blood Viscometers market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Product (Rotational Viscometers Product, Capillary Viscometers Product); End-Use (Hospitals End-Use, Diagnostics End-Use, Other End-Uses)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 41 Featured) -

• A&D HOLON Holdings Co., Ltd.
• AMETEK Inc. (Brookfield Engineering)
• Anton Paar GmbH
• ATAGO Co., Ltd.
• Benson Viscometers Ltd.
• BioFluid Technology Inc.
• Cambridge Viscosity Inc.
• Cannon Instrument Company
• Fann Instrument Company
• Grifols, S.A.
• Haemonetics Corporation
• Health Onvector
• KYOTO ELECTRONICS MANUFACTURING CO., LTD.
• LAUDA Scientific GmbH
• Lamy Rheology
• Microvisk Ltd.
• PCE Instruments
• Radiometer Medical ApS
• RheoSense Inc.
• Thermo Fisher Scientific Inc.

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

• 1. MARKET OVERVIEW
  • Influencer Market Insights
  • World Market Trajectories
  • Tariff Impact on Global Supply Chain Patterns
  • Blood Viscometers - Global Key Competitors Percentage Market Share in 2025 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
• 2. FOCUS ON SELECT PLAYERS
• 3. MARKET TRENDS & DRIVERS
  • Rising Focus on Hemorheology in Cardiovascular Risk Assessment Throws the Spotlight on Blood Viscometers
  • Growing Adoption in Clinical Diagnostics Spurs Demand for High-Precision Blood Viscosity Measurement Devices
  • Here's How Increased Awareness of Blood Flow Disorders Is Driving Use of Viscometers in Preventive Cardiology
  • Advancements in Point-of-Care Testing Technologies Expand the Accessibility of Bedside Viscosity Monitoring
  • Integration with Electronic Health Records and Smart Lab Systems Strengthens the Business Case for Digital Viscometers
  • Aging Population and Increased Prevalence of Hypertension and Diabetes Expand the Clinical Use of Blood Viscometry
  • Here's the Story: How Oncology and Critical Care Units Are Using Blood Viscometers to Monitor Treatment Impact
  • Surge in Research on Microcirculation and Thrombosis Supports Broader Application Across Specialty Clinics
  • Miniaturization and Automation Drive Innovation in Portable and User-Friendly Blood Viscometer Devices
  • Rising Demand from Pharmaceutical and Biotech Companies for Blood Rheology Data Fuels Use in Drug Trials
  • Global Expansion of Specialty Diagnostic Labs Creates New Market Opportunities for Advanced Viscometry Platforms
• 4. GLOBAL MARKET PERSPECTIVE
  • TABLE 1: World Blood Viscometers Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
  • TABLE 2: World Recent Past, Current & Future Analysis for Blood Viscometers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 3: World Historic Review for Blood Viscometers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 4: World 16-Year Perspective for Blood Viscometers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2025 & 2030
  • TABLE 5: World Recent Past, Current & Future Analysis for Rotational Viscometers Product by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 6: World Historic Review for Rotational Viscometers Product by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 7: World 16-Year Perspective for Rotational Viscometers Product by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 8: World Recent Past, Current & Future Analysis for Capillary Viscometers Product by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 9: World Historic Review for Capillary Viscometers Product by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 10: World 16-Year Perspective for Capillary Viscometers Product by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 11: World Recent Past, Current & Future Analysis for Hospitals End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 12: World Historic Review for Hospitals End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 13: World 16-Year Perspective for Hospitals End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 14: World Recent Past, Current & Future Analysis for Diagnostics End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 15: World Historic Review for Diagnostics End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 16: World 16-Year Perspective for Diagnostics End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 17: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 18: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 19: World 16-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030

III. MARKET ANALYSIS

• UNITED STATES
  • Blood Viscometers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
  • TABLE 20: USA Recent Past, Current & Future Analysis for Blood Viscometers by Product - Rotational Viscometers Product and Capillary Viscometers Product - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 21: USA Historic Review for Blood Viscometers by Product - Rotational Viscometers Product and Capillary Viscometers Product Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 22: USA 16-Year Perspective for Blood Viscometers by Product - Percentage Breakdown of Value Sales for Rotational Viscometers Product and Capillary Viscometers Product for the Years 2014, 2025 & 2030
  • TABLE 23: USA Recent Past, Current & Future Analysis for Blood Viscometers by End-Use - Hospitals End-Use, Diagnostics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 24: USA Historic Review for Blood Viscometers by End-Use - Hospitals End-Use, Diagnostics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 25: USA 16-Year Perspective for Blood Viscometers by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Diagnostics End-Use and Other End-Uses for the Years 2014, 2025 & 2030
• CANADA
  • TABLE 26: Canada Recent Past, Current & Future Analysis for Blood Viscometers by Product - Rotational Viscometers Product and Capillary Viscometers Product - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 27: Canada Historic Review for Blood Viscometers by Product - Rotational Viscometers Product and Capillary Viscometers Product Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 28: Canada 16-Year Perspective for Blood Viscometers by Product - Percentage Breakdown of Value Sales for Rotational Viscometers Product and Capillary Viscometers Product for the Years 2014, 2025 & 2030
  • TABLE 29: Canada Recent Past, Current & Future Analysis for Blood Viscometers by End-Use - Hospitals End-Use, Diagnostics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 30: Canada Historic Review for Blood Viscometers by End-Use - Hospitals End-Use, Diagnostics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 31: Canada 16-Year Perspective for Blood Viscometers by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Diagnostics End-Use and Other End-Uses for the Years 2014, 2025 & 2030
• JAPAN
  • Blood Viscometers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
  • TABLE 32: Japan Recent Past, Current & Future Analysis for Blood Viscometers by Product - Rotational Viscometers Product and Capillary Viscometers Product - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 33: Japan Historic Review for Blood Viscometers by Product - Rotational Viscometers Product and Capillary Viscometers Product Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 34: Japan 16-Year Perspective for Blood Viscometers by Product - Percentage Breakdown of Value Sales for Rotational Viscometers Product and Capillary Viscometers Product for the Years 2014, 2025 & 2030
  • TABLE 35: Japan Recent Past, Current & Future Analysis for Blood Viscometers by End-Use - Hospitals End-Use, Diagnostics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 36: Japan Historic Review for Blood Viscometers by End-Use - Hospitals End-Use, Diagnostics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 37: Japan 16-Year Perspective for Blood Viscometers by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Diagnostics End-Use and Other End-Uses for the Years 2014, 2025 & 2030
• CHINA
  • Blood Viscometers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
  • TABLE 38: China Recent Past, Current & Future Analysis for Blood Viscometers by Product - Rotational Viscometers Product and Capillary Viscometers Product - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 39: China Historic Review for Blood Viscometers by Product - Rotational Viscometers Product and Capillary Viscometers Product Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 40: China 16-Year Perspective for Blood Viscometers by Product - Percentage Breakdown of Value Sales for Rotational Viscometers Product and Capillary Viscometers Product for the Years 2014, 2025 & 2030
  • TABLE 41: China Recent Past, Current & Future Analysis for Blood Viscometers by End-Use - Hospitals End-Use, Diagnostics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 42: China Historic Review for Blood Viscometers by End-Use - Hospitals End-Use, Diagnostics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 43: China 16-Year Perspective for Blood Viscometers by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Diagnostics End-Use and Other End-Uses for the Years 2014, 2025 & 2030
• EUROPE
  • Blood Viscometers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
  • TABLE 44: Europe Recent Past, Current & Future Analysis for Blood Viscometers by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 45: Europe Historic Review for Blood Viscometers by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 46: Europe 16-Year Perspective for Blood Viscometers by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2025 & 2030
  • TABLE 47: Europe Recent Past, Current & Future Analysis for Blood Viscometers by Product - Rotational Viscometers Product and Capillary Viscometers Product - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 48: Europe Historic Review for Blood Viscometers by Product - Rotational Viscometers Product and Capillary Viscometers Product Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 49: Europe 16-Year Perspective for Blood Viscometers by Product - Percentage Breakdown of Value Sales for Rotational Viscometers Product and Capillary Viscometers Product for the Years 2014, 2025 & 2030
  • TABLE 50: Europe Recent Past, Current & Future Analysis for Blood Viscometers by End-Use - Hospitals End-Use, Diagnostics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 51: Europe Historic Review for Blood Viscometers by End-Use - Hospitals End-Use, Diagnostics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 52: Europe 16-Year Perspective for Blood Viscometers by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Diagnostics End-Use and Other End-Uses for the Years 2014, 2025 & 2030
• FRANCE
  • Blood Viscometers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
  • TABLE 53: France Recent Past, Current & Future Analysis for Blood Viscometers by Product - Rotational Viscometers Product and Capillary Viscometers Product - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 54: France Historic Review for Blood Viscometers by Product - Rotational Viscometers Product and Capillary Viscometers Product Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 55: France 16-Year Perspective for Blood Viscometers by Product - Percentage Breakdown of Value Sales for Rotational Viscometers Product and Capillary Viscometers Product for the Years 2014, 2025 & 2030
  • TABLE 56: France Recent Past, Current & Future Analysis for Blood Viscometers by End-Use - Hospitals End-Use, Diagnostics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 57: France Historic Review for Blood Viscometers by End-Use - Hospitals End-Use, Diagnostics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 58: France 16-Year Perspective for Blood Viscometers by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Diagnostics End-Use and Other End-Uses for the Years 2014, 2025 & 2030
• GERMANY
  • Blood Viscometers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
  • TABLE 59: Germany Recent Past, Current & Future Analysis for Blood Viscometers by Product - Rotational Viscometers Product and Capillary Viscometers Product - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 60: Germany Historic Review for Blood Viscometers by Product - Rotational Viscometers Product and Capillary Viscometers Product Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 61: Germany 16-Year Perspective for Blood Viscometers by Product - Percentage Breakdown of Value Sales for Rotational Viscometers Product and Capillary Viscometers Product for the Years 2014, 2025 & 2030
  • TABLE 62: Germany Recent Past, Current & Future Analysis for Blood Viscometers by End-Use - Hospitals End-Use, Diagnostics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 63: Germany Historic Review for Blood Viscometers by End-Use - Hospitals End-Use, Diagnostics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 64: Germany 16-Year Perspective for Blood Viscometers by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Diagnostics End-Use and Other End-Uses for the Years 2014, 2025 & 2030
• ITALY
  • TABLE 65: Italy Recent Past, Current & Future Analysis for Blood Viscometers by Product - Rotational Viscometers Product and Capillary Viscometers Product - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 66: Italy Historic Review for Blood Viscometers by Product - Rotational Viscometers Product and Capillary Viscometers Product Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 67: Italy 16-Year Perspective for Blood Viscometers by Product - Percentage Breakdown of Value Sales for Rotational Viscometers Product and Capillary Viscometers Product for the Years 2014, 2025 & 2030
  • TABLE 68: Italy Recent Past, Current & Future Analysis for Blood Viscometers by End-Use - Hospitals End-Use, Diagnostics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 69: Italy Historic Review for Blood Viscometers by End-Use - Hospitals End-Use, Diagnostics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 70: Italy 16-Year Perspective for Blood Viscometers by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Diagnostics End-Use and Other End-Uses for the Years 2014, 2025 & 2030
• UNITED KINGDOM
  • Blood Viscometers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
  • TABLE 71: UK Recent Past, Current & Future Analysis for Blood Viscometers by Product - Rotational Viscometers Product and Capillary Viscometers Product - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 72: UK Historic Review for Blood Viscometers by Product - Rotational Viscometers Product and Capillary Viscometers Product Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 73: UK 16-Year Perspective for Blood Viscometers by Product - Percentage Breakdown of Value Sales for Rotational Viscometers Product and Capillary Viscometers Product for the Years 2014, 2025 & 2030
  • TABLE 74: UK Recent Past, Current & Future Analysis for Blood Viscometers by End-Use - Hospitals End-Use, Diagnostics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 75: UK Historic Review for Blood Viscometers by End-Use - Hospitals End-Use, Diagnostics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 76: UK 16-Year Perspective for Blood Viscometers by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Diagnostics End-Use and Other End-Uses for the Years 2014, 2025 & 2030
• SPAIN
  • TABLE 77: Spain Recent Past, Current & Future Analysis for Blood Viscometers by Product - Rotational Viscometers Product and Capillary Viscometers Product - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 78: Spain Historic Review for Blood Viscometers by Product - Rotational Viscometers Product and Capillary Viscometers Product Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 79: Spain 16-Year Perspective for Blood Viscometers by Product - Percentage Breakdown of Value Sales for Rotational Viscometers Product and Capillary Viscometers Product for the Years 2014, 2025 & 2030
  • TABLE 80: Spain Recent Past, Current & Future Analysis for Blood Viscometers by End-Use - Hospitals End-Use, Diagnostics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 81: Spain Historic Review for Blood Viscometers by End-Use - Hospitals End-Use, Diagnostics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 82: Spain 16-Year Perspective for Blood Viscometers by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Diagnostics End-Use and Other End-Uses for the Years 2014, 2025 & 2030
• RUSSIA
  • TABLE 83: Russia Recent Past, Current & Future Analysis for Blood Viscometers by Product - Rotational Viscometers Product and Capillary Viscometers Product - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 84: Russia Historic Review for Blood Viscometers by Product - Rotational Viscometers Product and Capillary Viscometers Product Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 85: Russia 16-Year Perspective for Blood Viscometers by Product - Percentage Breakdown of Value Sales for Rotational Viscometers Product and Capillary Viscometers Product for the Years 2014, 2025 & 2030
  • TABLE 86: Russia Recent Past, Current & Future Analysis for Blood Viscometers by End-Use - Hospitals End-Use, Diagnostics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 87: Russia Historic Review for Blood Viscometers by End-Use - Hospitals End-Use, Diagnostics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 88: Russia 16-Year Perspective for Blood Viscometers by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Diagnostics End-Use and Other End-Uses for the Years 2014, 2025 & 2030
• REST OF EUROPE
  • TABLE 89: Rest of Europe Recent Past, Current & Future Analysis for Blood Viscometers by Product - Rotational Viscometers Product and Capillary Viscometers Product - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 90: Rest of Europe Historic Review for Blood Viscometers by Product - Rotational Viscometers Product and Capillary Viscometers Product Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 91: Rest of Europe 16-Year Perspective for Blood Viscometers by Product - Percentage Breakdown of Value Sales for Rotational Viscometers Product and Capillary Viscometers Product for the Years 2014, 2025 & 2030
  • TABLE 92: Rest of Europe Recent Past, Current & Future Analysis for Blood Viscometers by End-Use - Hospitals End-Use, Diagnostics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 93: Rest of Europe Historic Review for Blood Viscometers by End-Use - Hospitals End-Use, Diagnostics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 94: Rest of Europe 16-Year Perspective for Blood Viscometers by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Diagnostics End-Use and Other End-Uses for the Years 2014, 2025 & 2030
• ASIA-PACIFIC
  • Blood Viscometers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
  • TABLE 95: Asia-Pacific Recent Past, Current & Future Analysis for Blood Viscometers by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 96: Asia-Pacific Historic Review for Blood Viscometers by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 97: Asia-Pacific 16-Year Perspective for Blood Viscometers by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2025 & 2030
  • TABLE 98: Asia-Pacific Recent Past, Current & Future Analysis for Blood Viscometers by Product - Rotational Viscometers Product and Capillary Viscometers Product - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 99: Asia-Pacific Historic Review for Blood Viscometers by Product - Rotational Viscometers Product and Capillary Viscometers Product Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 100: Asia-Pacific 16-Year Perspective for Blood Viscometers by Product - Percentage Breakdown of Value Sales for Rotational Viscometers Product and Capillary Viscometers Product for the Years 2014, 2025 & 2030
  • TABLE 101: Asia-Pacific Recent Past, Current & Future Analysis for Blood Viscometers by End-Use - Hospitals End-Use, Diagnostics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 102: Asia-Pacific Historic Review for Blood Viscometers by End-Use - Hospitals End-Use, Diagnostics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 103: Asia-Pacific 16-Year Perspective for Blood Viscometers by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Diagnostics End-Use and Other End-Uses for the Years 2014, 2025 & 2030
• AUSTRALIA
  • Blood Viscometers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
  • TABLE 104: Australia Recent Past, Current & Future Analysis for Blood Viscometers by Product - Rotational Viscometers Product and Capillary Viscometers Product - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 105: Australia Historic Review for Blood Viscometers by Product - Rotational Viscometers Product and Capillary Viscometers Product Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 106: Australia 16-Year Perspective for Blood Viscometers by Product - Percentage Breakdown of Value Sales for Rotational Viscometers Product and Capillary Viscometers Product for the Years 2014, 2025 & 2030
  • TABLE 107: Australia Recent Past, Current & Future Analysis for Blood Viscometers by End-Use - Hospitals End-Use, Diagnostics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 108: Australia Historic Review for Blood Viscometers by End-Use - Hospitals End-Use, Diagnostics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 109: Australia 16-Year Perspective for Blood Viscometers by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Diagnostics End-Use and Other End-Uses for the Years 2014, 2025 & 2030
• INDIA
  • Blood Viscometers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
  • TABLE 110: India Recent Past, Current & Future Analysis for Blood Viscometers by Product - Rotational Viscometers Product and Capillary Viscometers Product - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 111: India Historic Review for Blood Viscometers by Product - Rotational Viscometers Product and Capillary Viscometers Product Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 112: India 16-Year Perspective for Blood Viscometers by Product - Percentage Breakdown of Value Sales for Rotational Viscometers Product and Capillary Viscometers Product for the Years 2014, 2025 & 2030
  • TABLE 113: India Recent Past, Current & Future Analysis for Blood Viscometers by End-Use - Hospitals End-Use, Diagnostics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 114: India Historic Review for Blood Viscometers by End-Use - Hospitals End-Use, Diagnostics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 115: India 16-Year Perspective for Blood Viscometers by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Diagnostics End-Use and Other End-Uses for the Years 2014, 2025 & 2030
• SOUTH KOREA
  • TABLE 116: South Korea Recent Past, Current & Future Analysis for Blood Viscometers by Product - Rotational Viscometers Product and Capillary Viscometers Product - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 117: South Korea Historic Review for Blood Viscometers by Product - Rotational Viscometers Product and Capillary Viscometers Product Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 118: South Korea 16-Year Perspective for Blood Viscometers by Product - Percentage Breakdown of Value Sales for Rotational Viscometers Product and Capillary Viscometers Product for the Years 2014, 2025 & 2030
  • TABLE 119: South Korea Recent Past, Current & Future Analysis for Blood Viscometers by End-Use - Hospitals End-Use, Diagnostics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 120: South Korea Historic Review for Blood Viscometers by End-Use - Hospitals End-Use, Diagnostics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 121: South Korea 16-Year Perspective for Blood Viscometers by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Diagnostics End-Use and Other End-Uses for the Years 2014, 2025 & 2030
• REST OF ASIA-PACIFIC
  • TABLE 122: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Blood Viscometers by Product - Rotational Viscometers Product and Capillary Viscometers Product - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 123: Rest of Asia-Pacific Historic Review for Blood Viscometers by Product - Rotational Viscometers Product and Capillary Viscometers Product Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 124: Rest of Asia-Pacific 16-Year Perspective for Blood Viscometers by Product - Percentage Breakdown of Value Sales for Rotational Viscometers Product and Capillary Viscometers Product for the Years 2014, 2025 & 2030
  • TABLE 125: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Blood Viscometers by End-Use - Hospitals End-Use, Diagnostics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 126: Rest of Asia-Pacific Historic Review for Blood Viscometers by End-Use - Hospitals End-Use, Diagnostics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 127: Rest of Asia-Pacific 16-Year Perspective for Blood Viscometers by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Diagnostics End-Use and Other End-Uses for the Years 2014, 2025 & 2030
• LATIN AMERICA
  • Blood Viscometers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
  • TABLE 128: Latin America Recent Past, Current & Future Analysis for Blood Viscometers by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 129: Latin America Historic Review for Blood Viscometers by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 130: Latin America 16-Year Perspective for Blood Viscometers by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2025 & 2030
  • TABLE 131: Latin America Recent Past, Current & Future Analysis for Blood Viscometers by Product - Rotational Viscometers Product and Capillary Viscometers Product - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 132: Latin America Historic Review for Blood Viscometers by Product - Rotational Viscometers Product and Capillary Viscometers Product Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 133: Latin America 16-Year Perspective for Blood Viscometers by Product - Percentage Breakdown of Value Sales for Rotational Viscometers Product and Capillary Viscometers Product for the Years 2014, 2025 & 2030
  • TABLE 134: Latin America Recent Past, Current & Future Analysis for Blood Viscometers by End-Use - Hospitals End-Use, Diagnostics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 135: Latin America Historic Review for Blood Viscometers by End-Use - Hospitals End-Use, Diagnostics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 136: Latin America 16-Year Perspective for Blood Viscometers by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Diagnostics End-Use and Other End-Uses for the Years 2014, 2025 & 2030
• ARGENTINA
  • TABLE 137: Argentina Recent Past, Current & Future Analysis for Blood Viscometers by Product - Rotational Viscometers Product and Capillary Viscometers Product - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 138: Argentina Historic Review for Blood Viscometers by Product - Rotational Viscometers Product and Capillary Viscometers Product Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 139: Argentina 16-Year Perspective for Blood Viscometers by Product - Percentage Breakdown of Value Sales for Rotational Viscometers Product and Capillary Viscometers Product for the Years 2014, 2025 & 2030
  • TABLE 140: Argentina Recent Past, Current & Future Analysis for Blood Viscometers by End-Use - Hospitals End-Use, Diagnostics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 141: Argentina Historic Review for Blood Viscometers by End-Use - Hospitals End-Use, Diagnostics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 142: Argentina 16-Year Perspective for Blood Viscometers by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Diagnostics End-Use and Other End-Uses for the Years 2014, 2025 & 2030
• BRAZIL
  • TABLE 143: Brazil Recent Past, Current & Future Analysis for Blood Viscometers by Product - Rotational Viscometers Product and Capillary Viscometers Product - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 144: Brazil Historic Review for Blood Viscometers by Product - Rotational Viscometers Product and Capillary Viscometers Product Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 145: Brazil 16-Year Perspective for Blood Viscometers by Product - Percentage Breakdown of Value Sales for Rotational Viscometers Product and Capillary Viscometers Product for the Years 2014, 2025 & 2030
  • TABLE 146: Brazil Recent Past, Current & Future Analysis for Blood Viscometers by End-Use - Hospitals End-Use, Diagnostics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 147: Brazil Historic Review for Blood Viscometers by End-Use - Hospitals End-Use, Diagnostics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 148: Brazil 16-Year Perspective for Blood Viscometers by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Diagnostics End-Use and Other End-Uses for the Years 2014, 2025 & 2030
• MEXICO
  • TABLE 149: Mexico Recent Past, Current & Future Analysis for Blood Viscometers by Product - Rotational Viscometers Product and Capillary Viscometers Product - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 150: Mexico Historic Review for Blood Viscometers by Product - Rotational Viscometers Product and Capillary Viscometers Product Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 151: Mexico 16-Year Perspective for Blood Viscometers by Product - Percentage Breakdown of Value Sales for Rotational Viscometers Product and Capillary Viscometers Product for the Years 2014, 2025 & 2030
  • TABLE 152: Mexico Recent Past, Current & Future Analysis for Blood Viscometers by End-Use - Hospitals End-Use, Diagnostics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 153: Mexico Historic Review for Blood Viscometers by End-Use - Hospitals End-Use, Diagnostics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 154: Mexico 16-Year Perspective for Blood Viscometers by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Diagnostics End-Use and Other End-Uses for the Years 2014, 2025 & 2030
• REST OF LATIN AMERICA
  • TABLE 155: Rest of Latin America Recent Past, Current & Future Analysis for Blood Viscometers by Product - Rotational Viscometers Product and Capillary Viscometers Product - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 156: Rest of Latin America Historic Review for Blood Viscometers by Product - Rotational Viscometers Product and Capillary Viscometers Product Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 157: Rest of Latin America 16-Year Perspective for Blood Viscometers by Product - Percentage Breakdown of Value Sales for Rotational Viscometers Product and Capillary Viscometers Product for the Years 2014, 2025 & 2030
  • TABLE 158: Rest of Latin America Recent Past, Current & Future Analysis for Blood Viscometers by End-Use - Hospitals End-Use, Diagnostics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 159: Rest of Latin America Historic Review for Blood Viscometers by End-Use - Hospitals End-Use, Diagnostics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 160: Rest of Latin America 16-Year Perspective for Blood Viscometers by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Diagnostics End-Use and Other End-Uses for the Years 2014, 2025 & 2030
• MIDDLE EAST
  • Blood Viscometers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
  • TABLE 161: Middle East Recent Past, Current & Future Analysis for Blood Viscometers by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 162: Middle East Historic Review for Blood Viscometers by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 163: Middle East 16-Year Perspective for Blood Viscometers by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2025 & 2030
  • TABLE 164: Middle East Recent Past, Current & Future Analysis for Blood Viscometers by Product - Rotational Viscometers Product and Capillary Viscometers Product - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 165: Middle East Historic Review for Blood Viscometers by Product - Rotational Viscometers Product and Capillary Viscometers Product Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 166: Middle East 16-Year Perspective for Blood Viscometers by Product - Percentage Breakdown of Value Sales for Rotational Viscometers Product and Capillary Viscometers Product for the Years 2014, 2025 & 2030
  • TABLE 167: Middle East Recent Past, Current & Future Analysis for Blood Viscometers by End-Use - Hospitals End-Use, Diagnostics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 168: Middle East Historic Review for Blood Viscometers by End-Use - Hospitals End-Use, Diagnostics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 169: Middle East 16-Year Perspective for Blood Viscometers by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Diagnostics End-Use and Other End-Uses for the Years 2014, 2025 & 2030
• IRAN
  • TABLE 170: Iran Recent Past, Current & Future Analysis for Blood Viscometers by Product - Rotational Viscometers Product and Capillary Viscometers Product - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 171: Iran Historic Review for Blood Viscometers by Product - Rotational Viscometers Product and Capillary Viscometers Product Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 172: Iran 16-Year Perspective for Blood Viscometers by Product - Percentage Breakdown of Value Sales for Rotational Viscometers Product and Capillary Viscometers Product for the Years 2014, 2025 & 2030
  • TABLE 173: Iran Recent Past, Current & Future Analysis for Blood Viscometers by End-Use - Hospitals End-Use, Diagnostics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 174: Iran Historic Review for Blood Viscometers by End-Use - Hospitals End-Use, Diagnostics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 175: Iran 16-Year Perspective for Blood Viscometers by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Diagnostics End-Use and Other End-Uses for the Years 2014, 2025 & 2030
• ISRAEL
  • TABLE 176: Israel Recent Past, Current & Future Analysis for Blood Viscometers by Product - Rotational Viscometers Product and Capillary Viscometers Product - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 177: Israel Historic Review for Blood Viscometers by Product - Rotational Viscometers Product and Capillary Viscometers Product Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 178: Israel 16-Year Perspective for Blood Viscometers by Product - Percentage Breakdown of Value Sales for Rotational Viscometers Product and Capillary Viscometers Product for the Years 2014, 2025 & 2030
  • TABLE 179: Israel Recent Past, Current & Future Analysis for Blood Viscometers by End-Use - Hospitals End-Use, Diagnostics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 180: Israel Historic Review for Blood Viscometers by End-Use - Hospitals End-Use, Diagnostics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 181: Israel 16-Year Perspective for Blood Viscometers by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Diagnostics End-Use and Other End-Uses for the Years 2014, 2025 & 2030
• SAUDI ARABIA
  • TABLE 182: Saudi Arabia Recent Past, Current & Future Analysis for Blood Viscometers by Product - Rotational Viscometers Product and Capillary Viscometers Product - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 183: Saudi Arabia Historic Review for Blood Viscometers by Product - Rotational Viscometers Product and Capillary Viscometers Product Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 184: Saudi Arabia 16-Year Perspective for Blood Viscometers by Product - Percentage Breakdown of Value Sales for Rotational Viscometers Product and Capillary Viscometers Product for the Years 2014, 2025 & 2030
  • TABLE 185: Saudi Arabia Recent Past, Current & Future Analysis for Blood Viscometers by End-Use - Hospitals End-Use, Diagnostics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 186: Saudi Arabia Historic Review for Blood Viscometers by End-Use - Hospitals End-Use, Diagnostics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 187: Saudi Arabia 16-Year Perspective for Blood Viscometers by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Diagnostics End-Use and Other End-Uses for the Years 2014, 2025 & 2030
• UNITED ARAB EMIRATES
  • TABLE 188: UAE Recent Past, Current & Future Analysis for Blood Viscometers by Product - Rotational Viscometers Product and Capillary Viscometers Product - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 189: UAE Historic Review for Blood Viscometers by Product - Rotational Viscometers Product and Capillary Viscometers Product Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 190: UAE 16-Year Perspective for Blood Viscometers by Product - Percentage Breakdown of Value Sales for Rotational Viscometers Product and Capillary Viscometers Product for the Years 2014, 2025 & 2030
  • TABLE 191: UAE Recent Past, Current & Future Analysis for Blood Viscometers by End-Use - Hospitals End-Use, Diagnostics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 192: UAE Historic Review for Blood Viscometers by End-Use - Hospitals End-Use, Diagnostics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 193: UAE 16-Year Perspective for Blood Viscometers by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Diagnostics End-Use and Other End-Uses for the Years 2014, 2025 & 2030
• REST OF MIDDLE EAST
  • TABLE 194: Rest of Middle East Recent Past, Current & Future Analysis for Blood Viscometers by Product - Rotational Viscometers Product and Capillary Viscometers Product - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 195: Rest of Middle East Historic Review for Blood Viscometers by Product - Rotational Viscometers Product and Capillary Viscometers Product Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 196: Rest of Middle East 16-Year Perspective for Blood Viscometers by Product - Percentage Breakdown of Value Sales for Rotational Viscometers Product and Capillary Viscometers Product for the Years 2014, 2025 & 2030
  • TABLE 197: Rest of Middle East Recent Past, Current & Future Analysis for Blood Viscometers by End-Use - Hospitals End-Use, Diagnostics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 198: Rest of Middle East Historic Review for Blood Viscometers by End-Use - Hospitals End-Use, Diagnostics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 199: Rest of Middle East 16-Year Perspective for Blood Viscometers by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Diagnostics End-Use and Other End-Uses for the Years 2014, 2025 & 2030
• AFRICA
  • Blood Viscometers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
  • TABLE 200: Africa Recent Past, Current & Future Analysis for Blood Viscometers by Product - Rotational Viscometers Product and Capillary Viscometers Product - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 201: Africa Historic Review for Blood Viscometers by Product - Rotational Viscometers Product and Capillary Viscometers Product Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 202: Africa 16-Year Perspective for Blood Viscometers by Product - Percentage Breakdown of Value Sales for Rotational Viscometers Product and Capillary Viscometers Product for the Years 2014, 2025 & 2030
  • TABLE 203: Africa Recent Past, Current & Future Analysis for Blood Viscometers by End-Use - Hospitals End-Use, Diagnostics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 204: Africa Historic Review for Blood Viscometers by End-Use - Hospitals End-Use, Diagnostics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 205: Africa 16-Year Perspective for Blood Viscometers by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Diagnostics End-Use and Other End-Uses for the Years 2014, 2025 & 2030

IV. COMPETITION